Fermentation membrane bioreactor platform for in space biomanufacturing
The FMBR platform addresses inefficiencies in batch fermentation by integrating ultrafiltration and automation for continuous biomass retention and product recovery, facilitating efficient biomanufacturing in space and remote settings.
Patent Information
- Application Number
- PCT/US2026/027455
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-08
- Filing Date
- 2026-05-08
- Publication Date
- 2026-11-12
AI Technical Summary
Conventional batch fermentation systems are inefficient and resource-intensive, requiring downtime for harvesting and cleaning, and continuous systems face challenges with biomass retention, contamination, and product recovery, especially in resource-limited environments like space missions.
A fermentation membrane bioreactor (FMBR) platform integrating microbial fermentation with ultrafiltration-based membrane separation, enabling continuous biomass retention and product recovery, with automated process control and sensor-based automation to mitigate contamination and foam, suitable for a broad spectrum of microbial hosts and target bioproducts.
The FMBR platform supports continuous biomanufacturing of value-added products using alternative feedstocks, reducing reliance on Earth-supplied materials and enabling efficient, self-sufficient production in space and remote environments.
Smart Images

Figure US2026027455_12112026_PF_FP_ABST
Abstract
Description
FERMENTATION MEMBRANE BIOREACTOR PLATFORM FOR IN SPACE BIOMANUFACTURINGCROSS-REFERENCES TO RELATED APPLICATIONS
[0001] This application claims priority to and the benefit of U.S. Provisional Application No. 63 / 802,029, filed May 8, 2025, titled “Fermentation Membrane Bioreactor for Biomanufacturing”, which is incorporated herein by reference in its entirety.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH
[0002] This invention was made with government support under 80NSSC18K1692 awarded by the National Aeronautics and Space Administration. The government has certain rights in the invention.FIELD
[0003] Disclosed herein are bioreactor systems and methods for the continuous biomanufacturing of value-added products using engineered and non-engineered microorganisms. More particularly, the present disclosure relates to a fermentation membrane bioreactor (FMBR) platform that integrates microbial fermentation with ultrafiltration-based membrane separation to enable continuous biomass retention, product recovery, and automated process control across a broad spectrum of microbial host organisms and target bioproducts. The disclosed platform is suited for terrestrial, remote, and extraterrestrial biomanufacturing applications, including orbital platforms, Lunar habitats, and Martian bases.BACKGROUND
[0004] Long-duration missions and early planetary habitation create constraints on mass, resupply frequency, and logistics. These constraints motivate systems that convert locally available or recycled resources into useful commodities, including chemicals, polymers, and pharmaceuticals. Advances in synthetic biology enable microbial biomanufacturing to serve as an alternative supply chain for producing both consumable and durable goods in a cost-effective manner.
[0005] Fermentation systems often operate in batch or fed-batch formats that require downtime for harvesting and cleaning and rely on downstream unit operations for solid-liquid separation. In resource-limited settings, these requirements increase consumables, crew time, and system footprint.
[0006] A membrane-integrated fermentation architecture that retains biomass while extracting product supports continuous production, particularly for organisms that secrete product extracellularly. Such architectures benefit from automation of pH, dissolved oxygen, temperature, level, and flow control to stabilize culture conditions over extended runs.
[0007] Operational challenges arise in practice, including contamination pathways introduced by non-autoclavable components, foaming that disrupts headspace and gas handling, mismatch between organism growth kinetics and hydraulic retention time, and product-specific recovery constraints when product accumulates intracellularly.
[0008] Accordingly, a need exists for a compact, modular, continuously operated fermentation platform that integrates membrane separation, sensor-based automation, and operational mitigations for contamination and foam, while supporting multiple organism / product modalities and alternative feedstocks.SUMMARY
[0009] Embodiments described herein relate to a fermentation membrane bioreactor (FMBR) platform for continuous biomanufacturing. In one embodiment, the FMBR integrates biotechnological and engineering principles to create a robust, efficient, and versatile system for in situ resource utilization (ISRU)-based biomanufacturing utilizing alternative feedstocks, ensuring self-sufficiency and reducing reliance on Earth-supplied materials.
[0010] In one embodiment, the present disclosure provides a fermentation membrane bioreactor system comprising: a main fermentation vessel; an ultrafiltration membrane module fluidly coupled to the fermentation vessel via a recirculation line; a plurality of peristaltic pumps configured to control feed flow, permeate extraction, recirculation, acid delivery, base delivery, and antifoam delivery; a dissolved oxygen (DO) sensor and a pH sensor disposed within the fermentation vessel; a liquid level sensor; a temperature control system comprising a water jacket and a chiller; and anautomated control and monitoring system configured to maintain user-defined set points for dissolved oxygen, pH, temperature, and liquid volume.
[0011] In one embodiment, the ultrafiltration membrane has a pore size of about 0.03 pm enabling continuous extraction of desired bioproducts in the permeate fraction while retaining microorganism biomass within the fermentation vessel, without disrupting active microbial metabolism.
[0012] In one embodiment, the present disclosure provides a method of continuously producing a bioproduct comprising: cultivating a bioproduct-producing microorganism in a fermentation vessel under controlled conditions; continuously extracting a bioproduct-containing permeate through an ultrafiltration membrane while retaining microorganism biomass within the fermentation vessel; continuously supplying fresh feedstock to the fermentation vessel in response to liquid level sensor feedback; and collecting the bioproduct from the permeate.
[0013] In one embodiment, the present disclosure provides methods and configurations for deploying the FMBR platform with a broad range of microbial chassis including, but not limited to, Pichia pastoris, Escherichia coli, Saccharomyces cerevisiae, Synechococcus elongatus, Vibrio natriegens, Bacillus subliHs. additional Bacillus sp., photosynthetic algae, Micrococcus sp., non-Streptomyces actinobacteria, and co-cultures of phototrophic and heterotrophic organisms.
[0014] In one embodiment, the FMBR platform is integrated within a closed-loop life support architecture aboard a spacecraft, orbital, Lunar base, or Martian base, wherein the FMBR serves as a production unit for one or more of pharmaceutical compounds, bioplastic precursors, food-grade nutrients, oxygen, biofuels, and structural polymer binders for in situ resource utilization-based additive manufacturing.
[0015] In one embodiment, the feedstock introduced into the FMBR comprises permeate from an anaerobic phototrophic membrane bioreactor (APMBR), optionally supplemented with dextrose, peptone, yeast extract, glucose, amino acids, mineral salts, antibiotics, antifoam agents, or combinations thereof.
[0016] In one embodiment, the disclosed platform is coupled to a phototrophic membrane bioreactor (PMBR), wherein the PMBR produces carbon-rich exometabolites, including sucrose, that serve as a feedstock for the FMBR, thereby creating a closed-loop, integrated biomanufacturing cascade.
[0017] In one embodiment, a fermentation membrane bioreactor (FMBR) platform is described that integrates a fermentation vessel, a recirculation line, an ultrafiltrationmembrane module configured to retain biomass while permitting permeation of clarified broth, and an automation and sensor suite that maintains set points for liquid level, pH, dissolved oxygen, temperature, and flow.
[0018] In one configuration, a permeate pump withdraws permeate across a hollowfiber membrane into a permeate tank at a controlled rate while a level sensor triggers feed addition to maintain a target working volume, establishing continuous operation with a defined hydraulic retention time.
[0019] In one embodiment, the platform supports extracellular product recovery through permeate harvest and supports intracellular product workflows through a membrane-bypass configuration coupled to downstream biomass processing such as centrifugation or extraction.
[0020] In one embodiment, the platform integrates condensate return from a condenser assembly to maintain volume balance, includes periodic membrane backwash to mitigate fouling, and executes closed-loop control of pH via acid / base dosing and dissolved oxygen via filtered air delivery to a sparger.
[0021] Traditional batch fermentation systems present significant limitations for resource-constrained and remote deployment environments. In conventional batch bioreactors, biomass and product accumulate together in a closed vessel, requiring periodic shutdown, harvest, sterilization, and restart cycles. These interruptions reduce volumetric productivity, increase contamination risk, and demand significant operator intervention, constraints that are prohibitive in space-based, remote, or resource-limited environments. Furthermore, intracellular product accumulation in batch systems requires whole-culture harvest and cell disruption, which consumes feedstock, loses viable biomass, and introduces logistical complexity.
[0022] Continuous fermentation systems address some of these deficiencies by allowing fresh feedstock to flow into the reactor while spent medium exits. However, without a mechanism to retain biomass, continuous systems are subject to “washout,” wherein the dilution rate exceeds the specific growth rate of the target microorganism, causing culture collapse.
[0023] Within the FMBR, genetically engineered bioproduct-producing microbes convert alternative feedstocks into target products via fermentation processes, which are then recoverable through downstream post-purification and processing methods. This configuration demonstrates the feasibility of synthesizing value-added compounds from simulated recycled wastewater and establishes a template for futuremicrobial fermentation processes including pharmaceuticals, polymers, and other high-value products.BRIEF DESCRIPTION OF THE FIGURES
[0024] Non-limiting embodiments of the present invention will be described by way of example with reference to the accompanying figures, which are schematic and are not intended to be drawn to scale. In the figures, each identical or nearly identical component illustrated is typically represented by a single numeral. For purposes of clarity, not every component is labeled in every figure, nor is every component of each embodiment of the invention shown where illustration is not necessary to allow those of ordinary skill in the art to understand the invention.
[0025] FIG. l is a schematic diagram of an FMBR system showing a reactor vessel 100 coupled to a recirculation line 200, a UF membrane module 300, a permeate pump 400 and permeate tank 410, a feed tank 500 and feed pump 510, a grouped sensor suite 600, and a controller 900 configured for continuous operation.
[0026] FIG. 2 shows the optimization of lactic acid production by S. cerevisiae in different growth media.
[0027] FIG. 3 shows the optimization of lactic acid production by S. cerevisiae using permeate based media. Panel A shows lactic acid levels after 24 hours of fermentation. Panel B shows lactic acid levels 5 days after the start of fermentation. Panel C shows a light microscopy image at 400x of CSM (control) media after 24 hours of fermentation. Panel D shows a light microscopy image at 400x of 100% permeate + 0 g / L regolith after 24 hours of fermentation.
[0028] FIG. 4 shows lactic acid concentration (g / L) over 10 days in flask-scale cultures of engineered Saccharomyces cerevisiae in permeate-based medium supplemented with regolith.
[0029] FIG. 5 shows direct polycondensation of lactic acid produced by S. cerevisiae. Panel A illustrates a brief protocol for direct polycondensation of lactic acid. Panel B shows1H-NMR results of the polycondensation of the fermented lactic acid. Panel C shows gel permeation chromatography (GPC) results from the direct polycondensation of reagent grade lactic acid.
[0030] FIG. 6 shows representative Opto 22 pH and dissolved oxygen graphs for the second control run.
[0031] FIG. 7 shows a comparison of optical density (OD) of the S. cerevisiae GMO control run 1 versus the two wild-type control runs.
[0032] FIG. 8 shows lactic acid concentration (g / L) and optical density (OD at 600 nm) for the S. cerevisiae GMO control including measurements from both the reactor tank and the effluent (permeate) tank.
[0033] FIG. 9 shows optical density (OD at 600 nm) of P. putida growing on LB in the FMBR over time.
[0034] FIG. 10 shows betaxanthin expression levels in the first semi-control FMBR run.
[0035] FIG. 11 shows an optical density (OD) profile of the engineered P. pastoris semi-control run in the FMBR. YPD media was used for the first 7 days. On day 7, 1.5 L of culture was harvested and the media was changed to APMBR permeate for the next 6 days. On day 13, 5 L of culture was harvested and 5 L of APMBR permeate was added.
[0036] FIG. 12 shows a normalized optical density (OD) profile of the genetically modified P. pastoris flask study results comparing growth in YPD Media, YPD Diluted Media, carbon-rich medium APMBR permeate (APMBR Rl), and APMBR permeate (APMBR Perm).
[0037] FIG. 13 shows a comparison of the optical densities of genetically modified P. pastoris in the FMBR with different growth media.
[0038] FIG. 14 shows flask study optical density (OD) of engineered E. coli using augmented APMBR permeates.
[0039] FIG. 15 shows P-carotene concentration of engineered A. coli using augmented APMBR permeates.
[0040] FIG. 16 shows the optical density (OD) of engineered E. coli for the LB control and augmented APMBR permeate experiments in the FMBR over time.
[0041] FIG. 17 shows the B-carotene concentration (mg / L) for the LB control and augmented APMBR permeate experiments in the FMBR over time.
[0042] FIG. 18 shows the optical density (OD at 730 nm) of wildtype S. elongatus cultured in batch mode in the PMBR.
[0043] FIG. 19 shows the optical density (OD) of genetically modified S. elongatus engineered to produce sucrose, cultured in continuous mode in the PMBR using BG- 11 control medium and APMBR permeate medium.DEFINITIONS
[0044] Unless defined otherwise, all technical and scientific terms used herein have the meaning commonly understood by a person skilled in the art to which this disclosure pertains.
[0045] This description enables one skilled in the art to make and use the disclosed platform, and it describes several embodiments, adaptations, variations, alternatives, and uses of the platform. These and other embodiments, features, and advantages of the present disclosure will become more apparent to those skilled in the art when taken with reference to the following detailed description in conjunction with the accompanying drawings.
[0046] Reference throughout this specification to “one embodiment,” “some embodiments,” “certain embodiments,” or “an embodiment” means that a particular feature, structure, material, or characteristic described in connection with the embodiment is included in at least one embodiment of the disclosure. Thus, the appearances of phrases containing the term “embodiment(s)” in various places throughout this specification are not necessarily referring to the same embodiment. Furthermore, the particular features, structures, materials, or characteristics are combined in any suitable manner in one or more embodiments.
[0047] When introducing elements of the embodiments described herein, the articles “a,” “an,” “the,” and “said” are intended to mean that there are one or more of the elements.
[0048] The terms “comprises,” “comprising,” or any variation thereof, are intended to cover a non-exclusive inclusion such that a system, method, or apparatus that comprises a list of components or steps does not include only those components or steps, but includes other components or steps not expressly listed or inherent to such system, method, or apparatus.
[0049] As used herein, the term “bioproduct” refers to any compound, molecule, polymer, protein, enzyme, therapeutic, pigment, metabolite, fuel, or material biosynthesized or accumulated by a microorganism as a result of its metabolic activity.
[0050] As used herein, the term “alternative feedstock” refers to any non-conventional nutrient source used to support microbial growth, including but not limited to wastewater, anaerobic phototrophic membrane bioreactor (APMBR)permeate, carbon dioxide, regolith mineral inputs, solar energy, and combinations thereof.
[0051] As used herein, the term “total organic carbon” or “TOC” refers to the total concentration of carbon present in organic compounds in a liquid sample, typically expressed as a mass of carbon per unit volume (e.g., mg / L).
[0052] As used herein, the term “permeate” refers to the liquid fraction that passes through an ultrafiltration membrane under applied pressure differential. The permeate contains dissolved bioproducts and is substantially free of microbial cells, which are retained on the feed side of the membrane.
[0053] As used herein, the term “permeate-based media” refers to a fermentation feedstock or growth medium formulated using permeate collected from an upstream membrane bioreactor, including but not limited to an anaerobic phototrophic membrane bioreactor (APMBR) or a phototrophic membrane bioreactor (PMBR), in place of or in combination with conventional synthetic or complex growth media. Permeate-based media comprises dissolved nutrients, organic carbon compounds, minerals, and other small molecules that have passed through the pores of a filtration membrane, while microbial biomass and high-molecular-weight macromolecules are retained on the retentate side.
[0054] In one embodiment, permeate-based media is used without supplementation.
[0055] In one embodiment, permeate-based media is supplemented with one or more of dextrose, peptone, yeast extract, glucose, amino acids, mineral salts, antibiotics, antifoam agents, or combinations thereof, and is referred to herein as augmented permeate-based media. Permeate-based media supports microbial growth at total organic carbon (TOC) concentrations in the range of 100 mg / L to 300 mg / L and is particularly suited for use in resource-limited, closed-loop, or in situ resource utilization (ISRU)-based biomanufacturing environments where conventional growth media components are not readily available.
[0056] As used herein, the term “hydraulic retention time” or “HRT” refers to the ratio of reactor liquid volume to volumetric flow rate of incoming feedstock, expressed in units of time. HRT governs the average residence time of dissolved components within the reactor vessel.
[0057] As used herein, the term “biomass retention” refers to the ability of the ultrafiltration membrane to prevent passage of microbial cells from the recirculationline into the permeate stream, thereby maintaining a high cell density within the fermentation vessel during continuous operation.
[0058] As used herein, the term “washout” refers to a condition in a continuous bioreactor wherein the volumetric dilution rate exceeds the specific growth rate of the microorganism, resulting in progressive loss of active culture from the reactor vessel.
[0059] As used herein, the term “zw situ resource utilization” or “ISRU” refers to the practice of collecting, processing, and using resources found at the location of a mission to reduce the mass, cost, and risk of space missions by decreasing reliance on Earth-supplied materials.
[0060] As used herein, the term “co-culture” refers to a bioreactor configuration in which two or more distinct microbial species or strains are cultivated together within the same vessel, optionally in a syntrophic or mutually beneficial metabolic relationship.
[0061] As used herein, the term “ultrafiltration” refers to a pressure-driven membrane separation process employing membranes with pore sizes typically in the range of 0.01 pm to 0.05 pm, capable of retaining microbial cells, cell debris, and high-molecular-weight macromolecules while allowing passage of dissolved small molecules, metabolites, and soluble bioproducts into the permeate.
[0062] As used herein, the term “transmembrane pressure” or “TMP” refers to the pressure differential across a membrane between the feed / retentate side and the permeate side, which is the driving force for permeation through the membrane pores.
[0063] As used herein, the term “retentate” refers to the concentrated fraction of fluid that does not pass through the ultrafiltration membrane and is returned to the fermentation vessel via the recirculation line, comprising primarily microbial biomass and retained macromolecules.
[0064] As used herein, the term “backwash” or “backwashing” refers to a periodic membrane maintenance procedure in which the direction of flow through the permeate pump is reversed, forcing permeate fluid from the permeate reservoir back through the ultrafiltration membrane in the direction opposite to normal permeation, thereby dislodging fouling deposits and restoring membrane permeability.
[0065] As used herein, the term “fed-batch mode” refers to a fermentation operating mode in which fresh feedstock is intermittently or continuously added to the reactor vessel without a corresponding removal of culture liquid, thereby increasing a working volume until a defined volume is reached; thereafter, the system transitionsto continuous operation in which culture liquid is withdrawn while feedstock is added to maintain the working volume.
[0066] As used herein, the term “anaerobic phototrophic membrane bioreactor” or “APMBR” refers to a biological wastewater treatment system that processes organic waste streams under anaerobic, phototrophic conditions, producing a nutrientcontaining permeate that serves as an alternative feedstock for downstream microbial fermentation processes.
[0067] As used herein, the term “phototrophic membrane bioreactor” or “PMBR” refers to a bioreactor system in which photosynthetic microorganisms are cultivated under illuminated conditions and separated from the culture medium by a membrane, enabling continuous product recovery and biomass retention, and optionally producing exometabolites, such as sucrose, that serve as feedstocks for downstream fermentation processes.
[0068] As used herein, the term “polylactic acid” or “PLA” refers to a biodegradable polyester derived from the condensation or ring-opening polymerization of lactic acid or lactide monomers, useful as a polymer binder, structural material, or additive manufacturing feedstock.
[0069] As used herein, the term “gel permeation chromatography” or “GPC” refers to a size-exclusion chromatography technique for characterizing polymer molecular-weight distribution by separating polymer chains based on hydrodynamic volume and reporting detector response as a function of elution time or elution volume.
[0070] As used herein, the term “weight-average molecular weight” or “Mw” refers to the molecular weight of a polymer calculated by weighting each chain’s molecular weight by its mass fraction in the distribution, and the term “poly dispersity index” or “PDF’ refers to a measure of breadth of the molecular-weight distribution defined as the ratio of Mw to the number-average molecular weight (Mn).
[0071] As used herein, “fermentation vessel” refers to the reactor vessel 100 described above.DETAILED DESCRIPTION
[0072] In the following sections, certain exemplary systems, configurations, and methods are described to detail embodiments of this disclosure. It will be obvious to one skilled in the art that practicing the described embodiments does not require the employment of all or even some of the specific details outlined herein, but rather thatoperating parameters, materials, microorganism selections, and other specific details are modified through routine experimentation. In some cases, well-known methods or components have not been included in the description.
[0073] The present disclosure is based on the development and demonstration of a modular FMBR platform that combines microbial fermentation in a reactor vessel 100 with ultrafiltration membrane filtration using a UF membrane module 300 to achieve continuous high-density cultivation and continuous product recovery from a variety of microbial host organisms operating on alternative feedstocks. The platform has been demonstrated with multiple host organisms and alternative feedstock inputs derived from wastewater treatment and is designed for adaptation to additional microbial hosts and target bioproducts.
[0074] In one embodiment, the FMBR platform comprises a modular system combining microbial fermentation and membrane filtration technologies within an integrated, automated process control framework.
[0075] In one embodiment, a commercial off-the-shelf (COTS) 10 L single-jacketed glass reactor serves as the core reactor vessel 100, usable at any working volume between 5 L and 10 L, providing operational flexibility and scalability.
[0076] In one embodiment, the FMBR design incorporates a polyvinylidene difluoride (PVDF) hollow fiber ultrafiltration (UF) membrane module 300 having a pore size of 0.03 pm, fluidly coupled to the reactor vessel 100 via a recirculation line 200. This UF membrane module 300 enables continuous extraction of the desired bioproduct in the permeate fraction while retaining microorganism biomass within the reactor vessel 100, without shutdown, harvest, or culture disruption. This feature is particularly advantageous for cultures that secrete target compounds extracellularly, facilitating product recovery while sustaining active microbial metabolism within the reactor vessel 100.
[0077] In one embodiment, the hollow fiber ultrafiltration membrane has a pore size selected from the group consisting of 0.01 to 0.05 pm, 0.01 to 0.03 pm and 0.02 to 0.04 pm.
[0078] In one embodiment, the reactor vessel 100 is surrounded by a water jacket cooled by a water jacket chiller 832, providing cooling when the fermentation reaction exceeds a user-defined temperature set point. In one embodiment, a temperature sensor disposed within the reactor vessel 100 provides temperature feedback as part of a grouped sensor suite 600.
[0079] In one embodiment, a dissolved oxygen probe and a pH probe are disposed within the reactor vessel 100, and a liquid level sensor and a temperature sensor provide liquid level sensing and temperature sensing within the reactor vessel 100, collectively represented as the grouped sensor suite 600.
[0080] In one embodiment, an air delivery subsystem provides air to the reactor vessel 100 for dissolved oxygen control.
[0081] In one embodiment, the reactor vessel 100 includes a mixing mechanism comprising a stirring motor driving an impeller within the reactor vessel 100. In one embodiment, a headplate defines multiple openings for fluid connections and instrumentation associated with the reactor vessel 100, including at least one return inlet and at least one port that supports aseptic reactor sampling.
[0082] In one embodiment, a condensing unit comprises a condensing coil 120 and a receiving flask assembly 122. Condensed vapor from the reactor vessel headspace accumulates in the receiving flask assembly 122, and a level sensor activates a dedicated condensate return pump 124 to return condensate into the recirculation line 200 and back into the reactor vessel 100.
[0083] In one embodiment, a control and monitoring system provides programmable control for the FMBR, including monitoring sensor outputs from sensors 600 and actuating pumps, enforcing safety interlocks, and providing operator oversight through a user interface.
[0084] In one embodiment, the control and monitoring system comprises an Opto 22 programmable automation controller executing software that accepts user-defined set points for liquid level high and low thresholds, pH, dissolved oxygen, temperature, permeate flow rate, feed flow rate, and impeller rotational speed. The Opto 22 system monitors sensor outputs from sensors 600, including the dissolved oxygen probe, pH probe, temperature probe, and liquid level sensor, and actuates the corresponding pumps and subsystems in response to deviations from the defined set points. The Opto 22 system additionally executes programmed safety modes that place the FMBR in a safe operating state if any anomalous condition, including over-pressure as detected by the pressure sensor coupled to the reactor vessel 100 headspace, is detected, suspending actuator operation until the anomaly is resolved by the operator. An antifoam delivery pump is also controllable through the Opto 22 graphical user interface (GUI), enabling the operator to set antifoam dosing rates directly.
[0085] In one embodiment, the Opto 22 system provides a graphical user interface accessible to the operator for monitoring real-time sensor data, adjusting set points, and reviewing historical run data during extended continuous operation.
[0086] In one embodiment, the FMBR comprises a pumping architecture governing fluid movement within the system, including: (i) a recirculation pump 210 configured to pass reactor contents through the UF membrane module 300 and return retentate to the reactor vessel 100 via the recirculation line 200; (ii) a feed pump 510 configured to deliver feed from a feed tank 500 responsive to a liquid level signal represented by sensors 600 to maintain a target working volume within the reactor vessel 100; (iii) a permeate pump 400 configured to draw permeate through the UF membrane module 300 into a permeate tank 410; (iv) an acid dosing pump 710 and a base dosing pump 712 configured to maintain pH at a user-defined set point; (v) a condensate return pump 124 activated based on condensate accumulation in the receiving flask assembly 122; and (vi) an optional antifoam delivery pump configured to deliver antifoam agent at a controlled volumetric rate.
[0087] In one embodiment, the permeate pump 400 drives the overall flow rate of the FMBR system by withdrawing a defined volume of permeate per unit time into the permeate tank 410, establishing a hydraulic retention time (HRT). In one embodiment, permeate pump 400 draws a negative pressure differential across the UF membrane module 300, forcing liquid to permeate through the pores into the permeate collection side and into the permeate tank 410. In one embodiment, as permeate is withdrawn, a liquid level signal represented by sensors 600 triggers feed pump 510 to dispense fresh feedstock from feed tank 500 until a high-level set point is restored.
[0088] In one embodiment, a feed line from feed tank 500 and a condensate return line from condensate return pump 124 are fluidly coupled into the recirculation line 200 upstream of a return inlet to the reactor vessel 100, such that incoming feedstock and condensate are delivered into the reactor vessel 100 without occupying additional headspace ports.
[0089] In one embodiment, periodic backwash events are performed by reversing the direction of the permeate pump 400, forcing permeate from the permeate tank 410 back through the UF membrane module 300 in the reverse direction of normal permeation. Backwashing removes fouled and caked-on material adhered to the membrane surfaces, preserving membrane flux and operational lifetime.
[0090] In one embodiment, when the pH of the reactor contents deviates from the operator-defined set point, controller 900 executing software activates the acid dosing pump 710 or the base dosing pump 712 to dispense reagent for a delivery interval of 10 seconds at a calibrated pump flow rate, allowing accurate calculation of the total cumulative volume of acid and base delivered over the duration of the run. The system then imposes a delay period to allow mixing to occur within the reactor vessel 100 before re-evaluating the pH. If the set point has not been restored after the delay period, an additional 10-second delivery of the reagent is performed. This cycle continues for the duration of the run.
[0091] In one embodiment, when the pH of the reactor contents deviates from the operator-defined set point, controller 900 executing software activates the acid dosing pump 710 or the base dosing pump 712 to dispense reagent for a delivery interval selected from the group consisting of 2-5 seconds, 3-8 seconds, 5-10 seconds, 10-15 seconds and 2-15 seconds.
[0092] In one embodiment, if the set point has not been restored after the delay period, an additional delivery of the reagent is performed for a time selected from the group consisting of 2- 5 seconds, 3-8 seconds, 5-10 seconds, 10-15 seconds and 2-15 seconds.
[0093] In one embodiment, the acid dosing pump 710 delivers phosphoric acid and the base dosing pump 712 delivers potassium hydroxide (KOH) to maintain the reactor vessel 100 at a user-defined pH set point.
[0094] In one embodiment, where a lactic acid-producing organism generates significant acid load during fermentation, a base concentration of IM KOH may prove insufficient to maintain the desired pH set point without adding excessive liquid volume to the reactor vessel 100. In such cases, the KOH concentration is increased, in one embodiment to 7M KOH, to reduce the volumetric addition burden and maintain volume balance within the reactor vessel 100 during extended continuous runs.
[0095] In one embodiment, when the dissolved oxygen of the reactor contents deviates below the operator-defined set point, the controller 900 executing software activates an air delivery subsystem to push air through a 0.22-micron air filter and into the reactor vessel 100 via the stainless steel sparger for a delivery interval of 10 seconds. The system then imposes a delay period to allow mixing and equilibration before re-evaluating the dissolved oxygen level. If the set point has not been restoredafter the delay period, an additional 10-second aeration cycle is performed. This cycle continues for the duration of the run.
[0096] In one embodiment, the FMBR provides active cooling via the water jacket chiller 832 when reactor contents exceed a defined temperature set point measured by sensors 600. When the set point is exceeded, coolant is circulated to remove heat via the water jacket associated with reactor vessel 100 until the internal reactor temperature returns to the set point.
[0097] In one embodiment, an alternative configuration incorporates a heating unit integrated with the recirculation line 200 to provide both heating and cooling.
[0098] In one embodiment, the FMBR operates in one of two configurations depending on intracellular or extracellular localization of the target bioproduct. For microorganisms that secrete desired product extracellularly into the fermentation medium, the UF membrane module 300 is engaged in the recirculation line 200, allowing continuous extraction of bioproduct into permeate withdrawn by permeate pump 400 to permeate tank 410 while retaining culture within reactor vessel 100. For microorganisms that accumulate product intracellularly, the UF membrane module 300 is bypassed in the recirculation line 200, and bioproduct is separated from harvested biomass via centrifugation, chemical lysis, mechanical disruption, or combinations thereof.
[0099] In one embodiment, the FMBR is operated in fed-batch mode during an initial biomass accumulation phase, with the UF membrane module 300 initially bypassed. Once sufficient biomass has accumulated, the UF membrane module 300 is engaged, and the system transitions to continuous product extraction mode with permeate withdrawal to permeate tank 410.
[0100] In one embodiment, the FMBR is operated in a continuous-flow mode wherein fresh feedstock from feed tank 500 is introduced into the reactor vessel 100 at a volumetric rate determined by permeate withdrawal via permeate pump 400, maintaining a defined HRT within which the culture achieves steady-state productivity without washout.
[0101] In one embodiment, the FMBR platform couples a stirred fermentation vessel with a recirculation line that passes reactor broth through a membrane module. In a representative mode, the membrane provides solid-liquid separation such that biomass is retained in the main vessel while permeate containing soluble product is withdrawn continuously.
[0102] In one embodiment, the platform incorporates sensors and actuators for automated control, including liquid level sensing, pH and dissolved oxygen probes, temperature measurement with jacketed cooling, peristaltic pumps for feed, permeate, recirculation, acid / base dosing, and optional antifoam dosing, as well as filtered aeration to a sparger.
[0103] In one embodiment, a condenser assembly captures headspace vapor and returns condensate to the system, supporting steady operation under evaporation-prone conditions.
[0104] In one embodiment, a control system executes set point maintenance and safety states based on sensor readings and actuator status, enabling extended continuous runs with reduced operator intervention.
[0105] In one embodiment, a biomanufacturing system comprises a reactor vessel 100 defining a culture volume, an impeller disposed in the reactor vessel 100, and a recirculation line 200 fluidly coupled to the reactor vessel 100.
[0106] In one embodiment, the recirculation line 200 comprises a UF membrane module 300 configured to retain microbial biomass while permitting permeation of clarified broth containing soluble product.
[0107] In one embodiment, the system comprises a permeate pump 400 configured to draw permeate across the UF membrane module 300 into a permeate tank 410.
[0108] In one embodiment, the system comprises a feed tank 500, a feed pump 510, and a liquid level sensor 600 disposed in the reactor vessel 100, where the liquid level sensor 600 provides a control signal that actuates feed pump 510 to maintain a target working volume.
[0109] In one embodiment, the system comprises a backwash routine in which permeate pump 400 reverses flow to dislodge solids from the UF membrane module 300.
[0110] In one embodiment, the system comprises a condensing coil 120, a receiving flask 122, and a condensate return pump 124 configured to return condensate to the reactor vessel 100 or recirculation line 200.[oni] In one embodiment, the system comprises a controller 900 configured to execute set points for liquid level thresholds, pH, dissolved oxygen, temperature, permeate flow, feed flow, and mixing speed and to actuate pumps responsive to sensor inputs.
[0112] In one embodiment, a biomanufacturing system comprises a fermentation vessel defining a culture volume, an impeller configured to mix the culture volume, and a recirculation line fluidly coupled to the fermentation vessel.
[0113] In one embodiment, the recirculation line comprises a membrane module comprising hollow fiber membranes having pores sized for ultrafiltration, where the membrane module is configured to retain microbial biomass while permitting permeation of clarified broth containing soluble product.
[0114] In one embodiment, the system comprises a permeate pump configured to apply a transmembrane pressure differential that drives permeation across the hollow fiber membranes into a permeate line and a permeate reservoir.
[0115] In one embodiment, the system comprises a feed reservoir, a feed pump, and a liquid level sensor disposed in the fermentation vessel, where the liquid level sensor is configured to trigger feed delivery responsive to a decrease in culture volume associated with permeate withdrawal.
[0116] In one embodiment, the system is configured to operate in a continuous mode defined by a target permeate withdrawal rate and a target feed addition logic that maintains a working volume and establishes a hydraulic retention time.
[0117] In one embodiment, the system comprises a backwash protocol executed by reversing flow through the membrane module using the permeate pump to dislodge fouling and extend membrane operational life.
[0118] In one embodiment, the system comprises a condensing coil configured to condense vapor from a headspace of the fermentation vessel, a receiving flask configured to collect condensate, a level sensor associated with the receiving flask, and a condensate return pump configured to return condensate to the recirculation line.
[0119] In one embodiment, the system comprises a pH probe and at least one dosing pump configured to deliver acid and base to maintain a pH set point under closed-loop control.
[0120] In one embodiment, the system comprises a dissolved oxygen probe and an aeration subsystem comprising an air pump, a 0.22 pm air filter, and a sparger configured to deliver filtered air to maintain a dissolved oxygen set point under closed-loop control.
[0121] In one embodiment, the system comprises a jacketed vessel and a chiller loop configured to remove heat and maintain a temperature set point, where temperature is measured by a temperature probe disposed in the culture volume.
[0122] In one embodiment, the system comprises a control unit executing software that accepts set points for liquid level high / low thresholds, pH, dissolved oxygen, temperature, permeate flow, feed flow, and impeller speed, and that actuates pumps and safety states responsive to sensor inputs.
[0123] In one embodiment, the system comprises sterilizable components selected for autoclave compatibility, and non-autoclavable components disinfected using alcohol-based protocols, with aseptic assembly conducted to reduce contamination risk.
[0124] In one embodiment, the system comprises carboy lids fitted with 0.22 pm inlet air filters for feed and permeate reservoirs to reduce airborne contamination during volume fluctuations.
[0125] In one embodiment, the system is configured for microorganisms that secrete target product extracellularly such that product is continuously recovered in permeate while biomass is retained within the fermentation vessel.
[0126] In one embodiment, the system is configured for microorganisms that accumulate target product intracellularly, and the recirculation line is routed to bypass the membrane module such that product recovery proceeds via biomass harvest and downstream separation.
[0127] In one embodiment, the system is configured to accept alternative feedstocks comprising wastewater-derived permeate produced by an upstream membrane bioreactor process, thereby supporting in situ resource utilization workflows.
[0128] In one embodiment, the system is configured for production of organic acids by engineered yeast strains, where closed-loop pH control compensates for acid accumulation using base dosing at a concentration selected to reduce volumetric addition burden.
[0129] In one embodiment, the system comprises a foam mitigation subsystem comprising an antifoam reservoir, an antifoam pump controlled through the control unit, and a delivery port configured to dispense antifoam responsive to observed foaming or a predefined dosing profile.
[0130] In one embodiment, the system comprises a pressure sensor coupled to the fermentation vessel headspace and a safety mode that halts one or more actuators responsive to pressure exceeding a threshold.
[0131] In one embodiment, the system supports cultivation of engineered Pichia pastoris configured to produce betaxanthin extracellularly and supports continuous recovery of fluorescent product in permeate under yeast-appropriate set points.
[0132] In one embodiment, the system supports cultivation of engineered Escherichia coli configured to accumulate P-carotene intracellularly and supports recovery via biomass harvesting and downstream extraction.
[0133] In one embodiment, the system supports cultivation of engineered Saccharomyces cerevisiae configured to produce lactic acid as a precursor for polymer formation, where lactic acid is recovered from culture liquid and purified for polymerization workflows.
[0134] In one embodiment, the FMBR supports cultivation of a Saccharomyces cerevisiae strain engineered to produce L-lactic acid by redirecting pyruvate flux away from the competing ethanol pathway. In one embodiment, this is achieved by integrating a. Bos taurus L-lactate dehydrogenase (LDH) gene into the PDC1 locus of the S. cerevisiae genome, thereby driving metabolic flux toward L-lactic acid accumulation and away from ethanol production. The resulting LDH-expressing strain secretes L-lactic acid into the fermentation medium, enabling continuous recovery of lactic acid in the permeate fraction via the UF membrane module 300.
[0135] In one embodiment, water chemistry analysis of the APMBR permeate, relative to conventional yeast-peptone-dextrose (YPD) growth medium, revealed a disparity in total organic carbon (TOC mg / L) content. YPD medium contains approximately 8,000 mg / L of TOC, whereas APMBR permeate contains approximately 150 mg / L of TOC (range of 100 mg / L to 300mg / L). Despite this disparity, diluted YPD medium formulated to match the TOC concentration of APMBR permeate supported microbial growth, establishing that low-carbon permeate-based media is capable of supporting the target organism under appropriate supplementation conditions.
[0136] In one embodiment, the system supports co-culture and sequential bioprocessing architectures in which a phototrophic culture produces a soluble carbon stream that serves as a feedstock for a downstream fermentation run.
[0137] In one embodiment, lactic acid produced by the FMBR platform is purified from the permeate fraction and processed into polylactic acid or lactic acid oligomers. In one embodiment, this is accomplished by direct polycondensation of lactic acid under dehydrating conditions at a temperature in the range of 150°C to 200°C for anextended reaction time sufficient to drive water removal and chain elongation. In one representative embodiment, polycondensation is conducted at approximately 180°C. In one embodiment, direct polycondensation of reagent-grade L-lactic acid produces poly-L-lactic acid having a weight-average molecular weight (Mw) of approximately 11 kDa and a poly dispersity index (PDI) of approximately 1.84 as determined by gel permeation chromatography (GPC), consistent with literature values for direct polycondensation processes in which water generation limits further chain elongation. In one embodiment, fermentation-derived lactic acid is used in place of reagent-grade lactic acid; in such cases, residual impurities from the fermentation medium may suppress chain growth, yielding short-chain oligomers.MethodsStart-Up and Inoculation
[0138] Media or alternative feedstock is sterilized and cooled in closed vessels fitted with 0.22 pm air filters. A seed culture is prepared by incubating the target microorganism in a liquid broth medium for approximately 48 hours prior to inoculation. The culture is then introduced into the feed tank 500 at an inoculation fraction of 1% of the total feed volume. Feed pump 510 is then activated to transfer the entire contents of the inoculated feed tank 500 into the reactor vessel 100.Controller 900 then initiates operation using set points for liquid level thresholds, pH, dissolved oxygen, temperature, permeate rate, and mixing speed.Continuous Operation with Membrane Separation (Extracellular Product Mode)
[0139] Culture liquid is recirculated through UF membrane module 300 by recirculation pump 210. Permeate pump 400 withdraws permeate to permeate tank 410 at a set rate, and liquid level sensor 600 triggers feed addition from feed tank 500 via feed pump 510 to maintain working volume in reactor vessel 100. Periodic backwash events reverse permeate pump 400 to reduce membrane fouling.Condensate collected in receiving flask 122 is returned using condensate return pump 124.Membrane-Bypass Operation (Intracellular Product Mode)
[0140] For intracellular products, the recirculation line 200 is routed to bypass UF membrane module 300, and culture is harvested by volume removal. Biomass is processed using downstream separation steps selected for the intracellular product.Results
[0141] Representative studies demonstrated platform operation with multiple organisms and product modalities, including wild-type P. putida, engineered P. pastoris producing betaxanthin, engineered E. coli producing P-carotene, and engineered S. cerevisiae producing lactic acid for polymer precursor workflows.Platform operation parameters including antifoam dosing protocols, sterilization procedures, and hydraulic retention time tuning were optimized for each organism to account for organism-specific kinetics and growth characteristics.
[0142] The FMBR supports cultivation of wild-type P.s putida as a non-engineered host organism for initial hardware validation. In a representative run, P. putida was cultured in Luria Broth (LB) medium with growth condition set points of 30°C for temperature and pH 7. Growth was measured by optical density at 600 nm. The permeate pump 400 was set to withdraw 1 L per day of permeate, and the feed pump 510 delivered 1 L per day of fresh LB medium in response to the liquid level sensor 600, establishing a hydraulic retention time (HRT) of 9 days within the reactor vessel 100. In a representative run, the culture reached a peak optical density of 18.1 on day 4 of operation before beginning to decline.
[0143] The FMBR platform was demonstrated with an engineered Saccharomyces cerevisiae strain configured to produce L-lactic acid as a bioplastic polymer precursor. In representative control runs, the GMO strain was cultured under continuous FMBR operation and growth was measured by optical density at 600 nm. Comparative OD profiles of the GMO control run against two wild-type S. cerevisiae control runs demonstrated that the GMO strain reached a lower peak optical density than both wild-type controls under equivalent conditions (see FIG. 7), consistent with the metabolic burden of redirecting pyruvate flux from ethanol production toward L-lactic acid accumulation. Lactic acid concentration was monitored over the course of the run by sampling both the reactor vessel and the permeate tank. L-lactic acid was detected and accumulated in the permeate fraction throughout the run, confirming continuous transmembrane recovery of the secreted bioproduct without culture disruption (see FIG. 8). The permeate tank data confirmed that L-lactic acid produced within the reactor vessel passed through the UF membrane module into the permeate stream, establishing the FMBR as a viable platform for continuous lactic acid extraction from actively growing cultures.
[0144] Betaxanthin production and extracellular recovery were demonstrated using an engineered Pichia pastoris strain operated in membrane-separation mode. In arepresentative semi-control FMBR run, the culture was inoculated and maintained in YPD medium for the first seven days of operation. On day 7, approximately 1.5 L of culture volume was harvested and the feedstock was transitioned from YPD medium to APMBR permeate for the subsequent six days. On day 13, approximately 5 L of culture was harvested and replaced with 5 L of APMBR permeate (see FIG. 11). Betaxanthin expression was quantified in permeate samples collected throughout the run by fluorescence measurement. Detectable betaxanthin levels were confirmed in the permeate fraction, demonstrating that the secreted fluorescent pigment passed through the 0.03 um UF membrane module and was recoverable from the permeate stream without disruption of the active culture (see FIG. 10). Comparison of optical density profiles across FMBR runs conducted with YPD control medium, augmented APMBR permeate, and unaugmented APMBR permeate confirmed that growth and betaxanthin productivity were highest in YPD control conditions, with augmented APMBR permeate supporting measurably improved growth relative to unaugmented permeate alone (see FIG. 13). These results establish continuous permeate-based fluorescent pigment recovery as a viable product modality for the FMBR platform.
[0145] Water chemistry analysis identified total organic carbon (TOC) as a primary differentiator between conventional rich media and wastewater-derived permeate used as a feedstock. The analysis showed that YPD contained approximately 8000 mg / L TOC, while APMBR permeate contained approximately 150 mg / L TOC, establishing that APMBR permeate is a low-carbon input stream relative to standard yeast growth media. This TOC contrast provides a quantitative framing for downstream media formulation: the baseline permeate TOC is orders of magnitude lower than rich medium, so growth and productivity outcomes in permeate-based media are expected to depend strongly on carbon availability and the bioavailability of carbon species, rather than on bulk nutrient presence alone.
[0146] TOC analysis was additionally employed as an indirect measure of sucrose export by the genetically modified S. elongatus strain during continuous-mode PMBR operation. In the BG-11 control experiment, TOC levels in the permeate samples did not show a measurable increase relative to the baseline medium, indicating that sucrose production by the S. elongatus strain, if occurring, was at concentrations below the detection sensitivity of the TOC measurement method under the tested conditions (see FIGs. 18-19). These results highlight TOC analysis as a useful screening tool for monitoring extracellular carbon export from phototrophicorganisms in the PMBR: when TOC does not rise, the downstream fermentation vessel receives no measurable increase in soluble carbon load from the upstream phototrophic stage, which constrains the achievable productivity of downstream sucrose-fed conversion steps.
[0147] To address the carbon and nutrient deficiency of the unaugmented APMBR permeate, augmentation strategies were evaluated for both P. pastoris and E. coli cultures. For the P. pastoris organism, augmentation with dextrose resulted in measurably improved growth compared to non-augmented APMBR permeate, though optical density did not reach levels achieved on YPD control medium.
[0148] For the engineered E. coli strain expressing B-carotene intracellularly, a flask study screening multiple augmentation formulations — including yeast extract, peptone, LB (yeast extract, peptone, and NaCl), dextrose, d-glucose, sucrose, and combinations thereof — identified augmentation with peptone as providing the most suitable growth conditions using APMBR permeate as the base medium (see FIGs. 14-15).
[0149] Subsequent FMBR-scale experiments confirmed that the E. coli culture grew to measurable density in both the LB control and the augmented APMBR permeate conditions, with peak B-carotene production of approximately 375 mg / L in the LB control and approximately 200 mg / L in the augmented APMBR permeate, both occurring on day 2 of fermentation (see FIGs. 16-17).EXAMPLES
[0150] Example A: A genetically modified S. cerevisiae strain producing lactic acid is run in continuous mode using wastewater-derived permeate supplemented with nutrients and carbon. Permeate is collected and analyzed for lactate concentration, and lactic acid is purified and processed into polylactic acid or oligomers using dehydration and condensation workflows. Direct polycondensation of lactic acid is performed under high-temperature, extended-time, dehydrating conditions at approximately 180°C (range of 150°C to 200°C). Validation using reagent-grade lactic acid confirmed production of poly-L-lactic acid with a weight-average molecular weight (Mw) of approximately 11 kDa and a poly dispersity index (PDI) of approximately 1.84, as determined by gel permeation chromatography (GPC), consistent with literature values for direct polycondensation processes that typically achieve modest molecular weights due to water generation limiting further chainelongation. When fermentation-derived lactic acid was used in place of reagent-grade lactic acid, residual impurities including glucose, peptides, and organic acids from the fermentation medium suppressed chain growth, yielding short-chain oligomers.
[0151] Example B: An engineered P. pastoris strain producing betaxanthin extracellularly is operated in membrane-separation mode, where permeate is continuously collected and fluorescence is monitored for product quantification.
[0152] Example C: An engineered A. coli strain producing P-carotene intracellularly is operated in membrane-bypass mode and biomass is harvested at defined intervals for extraction and quantification.
[0153] Example D: A phototrophic culture produces soluble carbon that is delivered as a feedstock to the FMBR for downstream fermentation to target metabolites.
[0154] Example E: Additional organisms operated in the platform include Vibrio natriegens, Bacillus subliHs. other Bacillus species, Micrococcus, non-Streptomyces actinobacteria, and edible algae, with configuration selected based on extracellular secretion versus intracellular accumulation of the target product.
Claims
CLAIMSWhat is claimed is:
1. A bioproduct produced by a fermentation membrane bioreactor (FMBR) process, wherein the FMBR comprises a fermentation vessel fluidly coupled via a recirculation line to a hollow fiber ultrafiltration (UF) membrane module having a pore size in the range of 0.01 pm to 0.05 pm, and wherein the bioproduct is recovered by:(i) continuously withdrawing a permeate fraction through the hollow fiber UF membrane module under a transmembrane pressure differential while retaining microbial biomass within the fermentation vessel; or(ii) routing the recirculation line to bypass the hollow fiber UF membrane module, harvesting microbial biomass from the fermentation vessel, and recovering the bioproduct from the harvested biomass.
2. The bioproduct of claim 1, wherein the bioproduct is recovered by continuously withdrawing the permeate fraction through the hollow fiber UF membrane module while retaining microbial biomass within the fermentation vessel.
3. The bioproduct of claim 2, wherein the hollow fiber UF membrane module has a pore size of 0.03 pm.
4. The bioproduct of claim 1, wherein the bioproduct is recovered by routing the recirculation line to bypass the hollow fiber UF membrane module, harvesting microbial biomass from the fermentation vessel, and recovering the bioproduct from the harvested biomass.
5. The bioproduct of claim 1, wherein the bioproduct is selected from the group consisting of an organic acid, a pigment, a fluorescent pigment or fluorescent compound, a carotenoid, a pharmaceutical compound, a bioplastic precursor, a foodgrade nutrient, a biofuel and a structural polymer binder.
6. The bioproduct of claim 2 or 3, wherein the bioproduct is L-lactic acid.
7. The bioproduct of claim 6, wherein the L-lactic acid is recovered from the permeate fraction of a continuous fermentation run in which the fermentation vessel ismaintained at a pH set point by closed-loop dosing of phosphoric acid and potassium hydroxide (KOH).
8. The bioproduct of claim 7, wherein a feedstock supplied to the fermentation vessel comprises permeate from an anaerobic phototrophic membrane bioreactor (APMBR) having a total organic carbon (TOC) content in a range of 100 mg / L to 300 mg / L.
9. The bioproduct of claim 8, wherein the feedstock further comprises at least one of dextrose, peptone, yeast extract, glucose, amino acids, mineral salts, antibiotics, or antifoam agent.
10. The bioproduct of claim 6, wherein the permeate fraction comprises the L-lactic acid and is substantially free of microbial cells.
11. A polylactic acid or lactic acid oligomer produced by polymerizing the L-lactic acid of claim 6.
12. The polylactic acid or lactic acid oligomer of claim 11, wherein polymerizing comprises direct polycondensation under dehydrating conditions at a temperature in a range of 150°C to 200°C.
13. The bioproduct of claim 2 or 3, wherein the bioproduct comprises betaxanthin produced extracellularly by an engineered Pichia pastoris strain cultured in the fermentation vessel.
14. The bioproduct of claim 13, wherein the permeate fraction, which contains betaxanthin, is quantified by fluorescence measurement.
15. The bioproduct of claim 4, wherein the bioproduct comprises P-carotene produced intracellularly by an engineered Escherichia coli strain cultured in the fermentation vessel.
16. The bioproduct of claim 15, wherein recovering the bioproduct from the harvested biomass comprises at least one of centrifugation, chemical lysis, mechanical disruption, or solvent extraction.
17. The bioproduct of claim 15 or 16, wherein the engineered Escherichia coli strain is cultured using a feedstock comprising anaerobic phototrophic membrane bioreactor (APMBR) permeate supplemented with at least one of dextrose, peptone, yeast extract, glucose, amino acids, mineral salts, antibiotics, or antifoam agent.
18. The bioproduct of claim 2 or 3, wherein membrane flux is maintained by periodically reversing flow through the hollow fiber UF membrane module to perform a backwash cycle that dislodges fouling deposits from the hollow fiber UF membrane module.
19. The bioproduct of claim 2 or 3, wherein evaporative loss from the fermentation vessel is compensated by condensing headspace vapor, collecting condensate in a receiving flask, and returning the condensate to the fermentation vessel or the recirculation line.
20. The bioproduct of claim 2 or 3, wherein dissolved oxygen is maintained at a user-defined set point by delivering filtered air through an air filter having a pore size of 0.22 pm to a sparger disposed within the fermentation vessel.
21. The bioproduct of claim 20, wherein filtered air is delivered for a delivery interval of 10 seconds when measured dissolved oxygen falls below the user-defined set point.
22. The bioproduct of claim 7, wherein potassium hydroxide (KOH) is dosed at a concentration in a range of 1 M to 7 M.
23. The bioproduct of claim 1, wherein the fermentation vessel has a working volume in a range of 5 L to 10 L.
24. A method of producing a bioproduct, comprising: cultivating a bioproductproducing microorganism in a culture volume of a fermentation vessel; recirculating culture liquid from the fermentation vessel through a hollow fiber ultrafiltration (UF) membrane module having a pore size in a range of 0.01 pm to 0.05 pm to retain microbial biomass while permitting permeation; withdrawing a permeate fraction comprising the bioproduct through the hollow fiber UF membrane module under atransmembrane pressure differential; and delivering feedstock to the fermentation vessel in response to a liquid level signal to maintain a target working volume while withdrawing the permeate fraction.
25. The method of claim 24, wherein the hollow fiber UF membrane module is formed of polyvinylidene difluoride (PVDF).
26. The method of claim 24, wherein the hollow fiber UF membrane module has a pore size of 0.03 pm.
27. The method of claim 24, further comprising performing a backwash operation by reversing flow through the hollow fiber UF membrane module to reduce fouling.
28. The method of any one of claims 24 to 27, further comprising maintaining a pH set point by dosing phosphoric acid and potassium hydroxide (KOH) under closed-loop control.
29. A bioproduct produced by a sucrose-fed closed-loop integrated biomanufacturing cascade, the cascade comprising: culturing an engineered Synechococcus elongatus strain configured to produce and secrete sucrose in a phototrophic membrane bioreactor (PMBR) under illuminated conditions; delivering sucrose recovered in a permeate stream or exometabolite stream from the PMBR as a feedstock to a downstream fermentation vessel; and cultivating a heterotrophic microorganism in the downstream fermentation vessel under closed-loop controlled conditions to convert the sucrose to a target bioproduct, wherein biomass of the heterotrophic microorganism is retained by a hollow fiber ultrafiltration (UF) membrane module having a pore size in a range of 0.01 pm to 0.05 pm.
30. The bioproduct of claim 29, wherein the hollow fiber UF membrane module has a pore size of 0.03 pm.
31. The bioproduct of claim 2 or 3, wherein the bioproduct is substantially free of microbial cells, cell debris, and high-molecular-weight macromolecules, the bioproduct having been obtained from the permeate fraction of a membraneseparation process in which microbial biomass is retained on a retentate side of the hollow fiber UF membrane module.
32. The bioproduct of claim 29, wherein the hollow fiber UF membrane module is formed of polyvinylidene difluoride (PVDF).
